Principia Biopharma Inc Quick Ratio (PRNB) starting from the second quarter 2020 to second quarter 2019, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Principia Biopharma Inc   (NASDAQ: PRNB)

Principia Biopharma Inc 's Quick Ratio

PRNB's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2020, Quick Ratio fell to 14.58 below Principia Biopharma Inc average.

Within Major Pharmaceutical Preparations industry 71 other companies have achieved higher Quick Ratio than Principia Biopharma Inc in second quarter 2020. While Quick Ratio total ranking has improved so far during the Q2 2020 to 252, from total ranking in the first quarter 2020 at 255.

Explain Quick Ratio?
How much Cash & cash equivalents PRNB´s has?
What are PRNB´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRNB Quick Ratio (Jun 30 2020)
Q2		 (Mar 31 2020)
Q1		 (Dec 31 2019)
Q4		 (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2
Y / Y Current Liabilities Change 151.74 % 112.79 % -57.45 % -73.22 % -84.65 %
Y / Y Cash & cash equivalent Change 86.67 % 90.36 % 78.37 % -19.96 % 312.57 %
Quick Ratio MRQ 14.58 17.28 30.5 17.84 19.66
PRNB's Total Ranking # 252 # 255 # 158 # 134 # 175
Seq. Current Liabilities Change 20.49 % 74.15 % 22.48 % -2.04 % 1.84 %
Seq. Cash & cash equivalent Change 1.63 % -1.3 % 109.4 % -11.12 % 3.63 %



Quick Ratio second quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 72
Healthcare Sector # 112
Overall Market # 252


Quick Ratio Statistics
High Average Low
30.5 17.08 5.97
(Dec 31 2019)   (Sep 30 2018)




Financial Statements
Principia Biopharma Inc 's Current Liabilities $ 22 Millions Visit PRNB's Balance sheet
Principia Biopharma Inc 's Cash & cash equivalent $ 317 Millions Visit PRNB's Balance sheet
Source of PRNB's Sales Visit PRNB's Sales by Geography


Cumulative Principia Biopharma Inc 's Quick Ratio

PRNB's Quick Ratio for the trailling 12 Months

PRNB Quick Ratio

 (Jun 30 2020)
12 Months		 (Mar 31 2020)
12 Months		 (Dec 31 2019)
12 Months		 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months
Y / Y Current Liabilities TTM Growth -19.77 % -62.29 % -67.96 % -43.16 % 29.88 %
Y / Y Cash & cash equivalent TTM Growth 56.68 % 66.21 % 96.76 % 188.07 % 1599.27 %
Quick Ratio TTM 18.7 20.85 22.27 13.25 9.57
Total Ranking TTM # 3593 # 3604 # 92 # 3812 # 3947
Seq. Current Liabilities TTM Growth 28.8 % 26.61 % -28.02 % -31.66 % -39.46 %
Seq. Cash & cash equivalent TTM Growth 15.51 % 18.49 % 20.98 % -5.38 % 22.54 %

Quick ratio ranking by company, industry and sector >> Back to PRNB Financial Strength Comparisons >> Go to Compare PRNB Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q2 2020 to $21.71 millions, cumulative Quick Ratio decreased to 18.7 above the PRNB average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 442 other companies have achieved higher Quick Ratio than Principia Biopharma Inc . While Quick Ratio overall ranking has improved so far to 3593, from total ranking during the twelve months ending first quarter 2020 at 3604.

Explain Quick Ratio?
How much Cash & cash equivalents PRNB´s has?
What are PRNB´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 443
Healthcare Sector # 828
Within the Market # 3593


trailing twelve months Quick Ratio Statistics
High Average Low
15.77 13.52 9.56
(Jun 30 2020)   (Jun 30 2019)




Companies with similar Quick Ratio in the quarter ending Jun 30 2020, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2020 MRQ Cash & cash equivalentJun 30 2020 MRQ Current Liabilities
Repare Therapeutics Inc   37.76 $ 369.933  Millions$ 9.797  Millions
Nextcure Inc   36.99 $ 309.335  Millions$ 8.362  Millions
Sol gel Technologies Ltd   36.84 $ 45.381  Millions$ 1.232  Millions
Matinas Biopharma Holdings Inc   35.22 $ 67.958  Millions$ 1.929  Millions
Oric Pharmaceuticals Inc   34.03 $ 196.642  Millions$ 5.778  Millions
Infinity Pharmaceuticals Inc   33.15 $ 42.730  Millions$ 1.289  Millions
Tff Pharmaceuticals Inc  31.78 $ 21.924  Millions$ 0.690  Millions
Kezar Life Sciences Inc   31.21 $ 157.471  Millions$ 5.045  Millions
Atrium Therapeutics Inc   30.33 $ 352.446  Millions$ 11.620  Millions
Viking Therapeutics Inc   30.10 $ 263.002  Millions$ 8.737  Millions
Ligand Pharmaceuticals Incorporated  27.67 $ 809.880  Millions$ 29.264  Millions
Ideaya Biosciences Inc   27.40 $ 170.414  Millions$ 6.220  Millions
Generation Bio Co   26.10 $ 301.086  Millions$ 11.536  Millions
Pliant Therapeutics Inc   25.96 $ 312.468  Millions$ 12.036  Millions
Biospecifics Technologies Corp  25.78 $ 99.052  Millions$ 3.842  Millions
Cryoport inc   24.96 $ 208.753  Millions$ 8.362  Millions
Calliditas Therapeutics Ab  24.52 $ 156.823  Millions$ 6.395  Millions
Rezolute Inc   24.00 $ 77.434  Millions$ 3.226  Millions
Silo Pharma Inc  23.96 $ 1.919  Millions$ 0.080  Millions
Applied Molecular Transport Inc   23.76 $ 163.263  Millions$ 6.870  Millions
Assembly Biosciences Inc   23.47 $ 226.714  Millions$ 9.659  Millions
Allakos Inc   23.24 $ 454.946  Millions$ 19.579  Millions
Lexaria Bioscience Corp   22.55 $ 2.052  Millions$ 0.091  Millions
Monopar Therapeutics Inc   21.89 $ 12.546  Millions$ 0.573  Millions
Gossamer Bio Inc   21.80 $ 600.364  Millions$ 27.544  Millions
Scpharmaceuticals Inc   21.72 $ 119.329  Millions$ 5.494  Millions
Constellation Pharmaceuticals Inc  21.38 $ 520.513  Millions$ 24.347  Millions
Palatin Technologies Inc   21.09 $ 82.852  Millions$ 3.928  Millions
Myokardia Inc   20.87 $ 918.053  Millions$ 43.991  Millions
Iveric Bio Inc   20.79 $ 245.735  Millions$ 11.818  Millions

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.